No CrossRef data available.
Article contents
Aiming at the Right Targets on Drug Price Reform
Published online by Cambridge University Press: 04 March 2024
Abstract
A lack of transparency and concerns over patients costs at the pharmacy counter have increased Congressional focus on pharmacy benefits management practices. However, applying regulations without transparency into pharmacy benefits managers practices could do more harm than good.
- Type
- Commentary
- Information
- Copyright
- © 2023 The Author(s)
References
What Medicare Part D Drug Plans Cover (2023), Medicare.gov, available at <https://www.medicare.gov/drug-coverage-part-d/what-medicare-part-d-drug-plans-cover> (last visited August 28, 2023).+(last+visited+August+28,+2023).>Google Scholar
Sachs, R., Trump Administration Releases Long-Awaited Drug Rebate Proposal (February 1, 2019), Health Affairs Blog, available at <https://www.healthaffairs.org/content/forefront/trump-administration-releases-long-awaited-drug-rebate-proposal> (last visited August 28, 2023).+(last+visited+August+28,+2023).>Google Scholar
Rowland, C., Drug Executives Grilled in Senate over High Prices (February 26, 2019), Washington Post, available at <https://www.washingtonpost.com/business/economy/drug-executives-grilled-in-senate-over-high-prices/2019/02/25/abc89c04-393f-11e9-aaae-69364b2ed137_story.html> (last visited August 28, 2023).+(last+visited+August+28,+2023).>Google Scholar
Incorporating the Effects of the Proposed Rule on Safe Harbors for Pharmaceutical Rebates in CBO’s Budget Projections—Supplemental Material for Updated Budget Projections: 2019 to 2029 (May 2019), Congressional Budget Office, available at <https://www.cbo.gov/system/files/2019-05/55151-SupplementalMaterial.pdf> (last visited August 28, 2023).+(last+visited+August+28,+2023).>Google Scholar
Herman, B., CVS Warns PBM Reforms “Could Lead to Higher Costs” (May 31, 2023), STAT, available at <https://www.statnews.com/2023/05/31/cvs-pbm-reforms-rebates-spread-pricing/> (last visited August 28, 2023).+(last+visited+August+28,+2023).>Google Scholar
See Examining Policies That Inhibit Innovation and Patient Access: Hearing before the House Ways and Means Subcommittee on Health, 118th Cong., (2023) (testimony of Benjamin N. Rome, M.D., M.P.H.) available at <https://waysandmeans.house.gov/wp-content/uploads/2023/05/Rome-Testimony.pdf> (last visited November 27, 2023).+(last+visited+November+27,+2023).>Google Scholar
Slifer, E. and Llamas, A., Bipartisan Congressional Support for PBM Reform Grows (June 21, 2023), The Commonwealth Fund, available at <https://www.commonwealthfund.org/blog/2023/bipartisan-congressional-support-pbm-reform-grows> (last visited August 28, 2023).+(last+visited+August+28,+2023).>Google Scholar
Wyden, Senator Ron, Wyden Statement at Finance Committee Markup of the Modernizing and Ensuring PBM Accountability Act (July 26, 2023), United States Senate Committee on Finance, available at <https://www.finance.senate.gov/chairmans-news/wyden-statement-at-finance-committee-markup-of-the-modernizing-and-ensuring-pbm-accountability-act> (last visited August 28, 2023).+(last+visited+August+28,+2023).>Google Scholar
Cohen, J., PBM Reform Legislation may be One Step Closer to Reality, but It’s Missing Two Key Components (May 13, 2023), Forbes, available at <https://www.forbes.com/sites/joshuacohen/2023/05/13/pbm-reform-legislation-may-be-one-step-closer-to-reality-but-its-missing-two-key-components/> (last visited August 28, 2023).+(last+visited+August+28,+2023).>Google Scholar
Dusetzina, S.B. et al., “Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending,” JAMA Internal Medicine 177 (2017): 1185–8.CrossRefGoogle ScholarPubMed